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Abstract
Objective: Lavender is an aromatic shrub belonging to the Lamiaceae family. The
flowers and leaves in different forms of extracts are used as herbal medicine. The
accumulation of amyloid beta (Aβ) plaques, reduction of acetylcholine due to
hyperactivity of acetylcholinesterase, and glutamate neurotoxicity are known to be
involved in decreased level of cognitive function. In our previous study, we proved
that the aqueous extract of lavender improves learning and memory. This in vitro
study was designed to evaluate antiaggregative, antioxidant, and antiacetylcholines-
terase activities of the herbal medicine.
Methods: Thin layer chromatography, high‐performance liquid chromatography,
thioflavin, atomic force microscope (AFM), Elleman, and 2,2‐diphenyl‐1‐picryl hydrazyl
techniques were used for qualitative analysis, quantitative analysis, antiaggregative
characteristics, anti‐acetylcholinestrase activity and antioxidant activity of the lavender
extract, respectively.
Results: We found chromatographic peaks of caffeic acid and luteolin‐7‐glycosid in
the lavender extract. Our results indicated that aqueous extract of lavender dose‐
dependently inhibits the formation of Aβ aggregate. The AFM technique showed that
lavender largely diminished the Aβ fibril formation. We also observed a considerable
radical scavenging activity of the extract.
Conclusions: Prevention of Aβ plaque formation and antioxidant activity along with
nontoxic features of the lavender extract promise possible effectiveness of this plant
on improving some neurological disorders including Alzheimer’s disease.
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1 | INTRODUCTION
Lavandula angustifolia (lavender), also known as Lavandula officinalis, is
a strongly aromatic shrub in the Lamiaceae family (Oskouie, Yekta,
Tavirani, Kashani, & Goshadrou, 2018). Lavender is native to the
Mediterranean region and grows as high as 1–2m with evergreen
leaves (Niksic et al., 2016). The flowers and leaves of lavender either
in the form of mostly essential oil or different forms of extracts are
traditionally used as therapeutics (Gilani et al., 2000; Méndez‐Tovar,
Herrero, Pérez‐Magariño, Pereira, & Asensio, 2015; Umezu et al.,
2006). The main constituents of the essential oil of the herbal
medicine are the linalool and linalyl acetate (Caputo, Souza, Alloisio,
Cornara, & De Feo, 2016). Several studies have shown that lavender
displays multiple pharmacological effects, such as sedative, antic-
onvulsant, analgesic, and local anesthetic roles (Silva et al., 2015;
Soheili, Salami, Haghir, Zali, & Rezaei Tavirani, 2014). It also displays
tranquilizing role with soothing and relaxing effect on the nervous
system (Lopez, Nielsen, Solas, Ramirez, & Jager, 2017). Data showing
the effects of the aqueous extract of lavender is limited. In our
previous studies, we showed that the aqueous extract of lavender
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improves the impaired learning and memory (Kashani, Tavirani,
Talaei, & Salami, 2011) and positively affect the deteriorated synaptic
transmission in an animal model of Alzheimer's disease (AD) (Soheili,
Rezaei Tavirany, & Salami, 2015). It also clears the amyloid beta (Aβ)
plaques from the hippocampus of these animals (Soheili, Tavirani, &
Salami, 2012). Accordingly, the present study aimed to standardize
the extract based on caffeic acid and luteolin-7-glycosid. Caffeic acid
is abundantly found in medicinal plants with anti-inflammatory and
antioxidative properties, which is beneficial against neurodegenera-
tive diseases (Park et al., 2004; Parlakpinar, Sahna, Acet, Mizrak, &
Polat, 2005; Wei et al., 2008). Luteolin, a flavonoid found in various
edibles, has antioxidant and anti‐inflammatory activity both in vitro
and in vivo (Lopez‐Lazaro, 2009). It also has preventive and
therapeutic value for neurodegenerative diseases including AD and
ameliorates the cognitive impairment in various AD animal models
(Fu et al., 2014; Zuo, Hemmelgarn, Chuang, & Best, 2015). Luteolin
has specific binding sites for AChE and Aβ42, which might result in
the inhibition of AChE activity and Aβ disaggregation or prevent
plaque formation (Ali et al., 2018).
In the following, we examined the probable effect of aqueous
extract of lavender on in vitro polymerization of Aβ monomers,
reduction of acetylcholinesterase (AChE) activity, and its anti-oxidant
effect. All the above are known as pathological symptoms of AD.
2 | MATERIALS AND METHODS
2.1 | Chemicals
The standards of caffeic acid and luteolin were purchased from Extra
Synthesis (Genay, France). Water used in high‐performance liquid
chromatography (HPLC) and sample preparation was produced with
a Super Purity Water System. Methanol, dimethylsulfoxide (DMSO),
and other organic solvents (for HPLC or analytical grade) were
obtained from Merck (Darmstadt, Germany). Aβ proteins (1–42),
thioflavin T, AChE enzyme, acetylthiocholine iodide (ATCI), 5,5′‐
dithiobis [2‐nitrobenzoic acid] (DTNB), and 2,2‐diphenyl‐1‐picryl
hydrazyl (DPPH) were purchased from Sigma‐Aldrich (MO). All the
reagents and drugs used were of analytical grade.
2.2 | Aqueous extract preparation
For extract preparation, 300 g of dried Lavandula angustifolia leaves
and flowers (with voucher specimens of 1092) were mixed with
1,000ml boiled water. The mixture was filtered after 4 hr and
concentrated by vaporizing on a water bath.
2.3 | Sample preparation
For HPLC analysis, 50mg of ground sample was extracted with 25ml
water and sonicated for 10min. Then, it was centrifuged at
4,500 rpm for 5 min. The residual solid was further extracted with
20ml of water, sonicated for 5 min, and centrifuged at 4,500 rpm for
5min. The supernatants were transferred to a 50ml volumetric ﬂask
and water up to 50ml was added. Before HPLC analysis, the sample
was centrifuged at 13,000 rpm for 10min.
2.4 | TLC analysis
To chemically characterize the presence of caffeic acid and luteolin in
aqueous extract of lavender, TLC was carried out with chloroform,
acetone, and acid formic as the solvent system.
2.5 | Instrumentation of HPLC
An HP 1100 series liquid chromatography system of Shimadzu was
used. The column, Kingsorb 5 µl C8 (250 × 4.6mm), with photodiode
array detector was used. In this experiment, methanol–water and
acetonitrile–water in combination with acetic acid or phosphoric acid
were tested as the mobile phase.
Then, a 75 min of run with ﬂow rate of 0.8 ml/min was
performed. The sample injection volume was 100 µl with a
detection wavelength of 325–350 nm. Before injection of the
lavender extract, working standard solutions of caffeic acid and
luteolin with a concentration of 1.25, 2.5, 5, and 10 µg/ml,
respectively, were injected into the HPLC. The standard peaks
were depicted and the peaks formula at 325 and 350 nm were
obtained. Finally, the lavender extract in a concentration of
500 µg/ml was injected and the concentration percent of caffeic
acid and luteolin in the extract were calculated. All experiments
were carried out in triplicate.
2.6 | Thioflavin T measurement
The Aβ monomers were dissolved in DMSO (Aβ‐DMSO) and kept
under −20°C until use. The experiments were performed on Aβ‐
DMSO in two different conditions. In the control group (CON), the
Aβ‐DMSO was added to Tris buffer (pH 7.4) and the mixture was
incubated at 37°C for 24 hr. In another group, (Treat) Aβ‐DMSO was
added to Tris buffer + extract and maintained under the same
condition. The Treat group itself was subdivided to four groups
receiving 1, 5, 10, and 100 µg/ml of the extract and were named as
Treat‐1, Treat‐5, Treat‐10, and Treat‐100, respectively. After
incubation, 1 mg thioflavin T was dissolved in 1ml deionized water
and added to the mixtures. Then, using a microplate reader
(Spectramax Gemini XS; Molecular Devices, Sunnyvale, CA) with a
special filter set (excitation at 442 nm and emission at 485 nm), the
fluorescence of the thioflavin T bound to Aβ aggregates was
measured. Finally, optical density (OD) of the control group was
compared with that of the four treated groups.
2.7 | AFM imaging
The samples were imaged using a Veeco atomic force microscope
(AFM) with the noncontact imaging mode. AFM consists of a sharp
tip (probe) at its end. When the tip is brought into proximity of a
sample surface, mechanical contact of the tip and the sample lead to
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image formation. The method was carried on as previously described
(Soheili, Khalaji, Mirhashemi, & Salami, 2019). In brief, the samples
were prepared, for AFM imaging, by drying a 5 µL sample from the
Treat‐100 group on freshly cleaved mica plates. Mica plates
containing the samples were dried for about 2 min at ambient
temperature. After that, the buffer and salt components were
washed from the surface of mica with deionized water and the mica
was dried again. This procedure ensures that the ﬁbrils and peptide
molecules remain attached to the mica surface, possibly due to the
negative charge on the surface of mica plates.
2.8 | Cell lines
Human hepatoma G2 (HepG2) cell line was obtained from Pasture
Institute of Iran (Tehran, Iran). The cell line (100,000 cells/well) was
cultured in a suitable medium for desired growth, along with 5% or
10% fetal bovine serum in a humidified incubator at 37°C in an
atmosphere of 5% CO2. The cells were treated with different
concentrations of the aqueous extract of lavender (6.25, 12.5, 25, 50,
and 100 μg/ml) for 24 hr for the determination of lavender
cytotoxicity.
2.9 | AChE inhibitory assay
Ellman assay is usually applied to define the cholinesterase activity of
materials. In 96‐well plates, 125 μl of 3 mM DTNB, 25 μl of 15mM
ATCI, and 50 μl of phosphate buffer (pH 8) and 25 μl of the samples
(extract or methanol) were dissolved in methanol (3 mg/ml) and
added to the wells. A concentration range of lavender extract (100,
150, 200, 250, and 300 μg/ml) was used in the AChE assay
experiments. The absorbance was measured at 405 nm every 13 s
for 65 s; 25 μl of 0.22 U/ml of AChE enzyme was then added and the
absorbance was again read every 13 s for 104 s. The absorbance was
plotted against time and the enzyme activity was calculated from the
slope of the line. Any increase in the absorbance due to the
nonenzymatic hydrolysis of the substrate was corrected by subtract-
ing the rate of reaction before addition of the enzyme from the rate
after addition of the enzyme. Percentage of enzyme inhibition was
calculated by comparing the rates of the samples with the blank.
2.10 | 2,2-Diphenyl-1-picryl hydrazyl (DPPH)
radical scavenging assay
This method is one of the most extensively used antioxidant assays
for plant samples. To determine DPPH radical scavenging activity of
lavender samples, 2 ml of 100 μM DPPH methanol solution was
added to 2ml of the various concentrations of the extract. The
mixture was shaken vigorously and left at room temperature for
30min. Then, the absorbance of the solution was read at 517 nm and
the antioxidant activity was calculated using the following equation:
Percent of scavenging capacity = 100 − [(ABS of sample −ABS of
blank) × 100/ABS of control].
A mixture of 2 ml methanol with 2 ml plant extract solution
was used as the blank, whereas 2 ml DPPH solution plus 2 ml
solvent corresponding to the extract was used as the negative
control. Vitamin C was used as a positive control with
concentrations of 1, 1.5, 2, 2.5, 3 μg/ml, respectively. The extract
concentration providing 50% inhibition (IC50) was calculated
from the plot of inhibition percentage against extract concentra-
tion. All tests were performed in triplicates.
2.11 | Data analysis
Statistical analysis was performed using one‐way analysis of
variance followed by LSD post hoc test. The differences were
considered significant for p < 0.05. The data are expressed as
mean ± SEM.
3 | RESULTS
3.1 | Standardization of aqueous extract of
lavender
In this experiment, methanol–water and acetonitrile–water in
combination with acetic acid or phosphoric acid were tested as
mobile phase. Meanwhile, it is necessary to clarify whether a
gradient or isocratic system has been used. The best separation
of caffeic acid and luteolin‐7‐glycosid was found in methanol–
water system containing phosphoric acid (Figure 1).
Comparing the lavender and standard chromatograms, the
chromatographic peaks of caffeic acid and luteolin‐7‐glycosid were
confirmed. Figure 2a,b show the spectra of caffeic acid and luteolin‐
7‐glycosid. The best separation was achieved within 21min for
caffeic acid and 53min for luteolin‐7‐glycosid at 325 nm (Table 1).
The amount of caffeic acid and luteolin‐7‐glycosid in 100 µl of the
aqueous extract of lavender were estimated at 13 and 41 µg/ml,
respectively.
F IGURE 1 HPLC profile of aqueous extract of lavender. (a) and
(b) represents caffeic acid and luteolin peaks, respectively. HPLC:
high‐performance liquid chromatography
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3.2 | Antiaggregative effect
With respect to the clearance effect of lavender on Aβ fibrils
from the hippocampus of the Aβ‐treated rats (Soheili et al., 2012),
concentration dependencies were examined by using the thio-
flavin T method (Figure 3). We observed that the extract induced
a concentration‐dependent decline in fluorescence intensity in
Aβ 1–42 (F4, 16 = 4.803; p = 0.01). Our results showed that the
dose of 1 µg/ml had no significant effect on Aβ aggregation
(p = 0.273). The doses of 5, 10, and 100 µg/ml, respectively, had a
considerable effect on Aβ polymerization and aggregate forma-
tion (p = 0.025, 0.008, and 0.001, respectively). These findings
prove that the aqueous extract of lavender dose‐dependently
inhibits the formation of Aβ aggregate.
3.3 | AFM imaging
To visualize the effect of the herbal extract on Aβ fibril formation, the
fibrils were observed by AFM technique. A clear and shining paired
helical Aβ was visible in the Aβ treated without the extract, which is
reflected in thicker and longer aggregated fibrils (Figure 4a,b). In
contrast, the incubation of Aβ with the aqueous extract of lavender
largely diminished the fibril formation (Figure 5a,b). The fibril
characteristics of the Aβ peptide treated with and without extract
are summarized in Table 2. Figures 4,5c illustrate height profiles of
the fibrils with and without extract, respectively.
3.4 | Cytotoxic activity
We also evaluated the cytotoxicity effect of aqueous extract of
lavender on the HepG2 cell line. The microscopic evaluation of
the HepG2 cells indicated no granulation and no adherence to the
flask of the treated cells when compared with the control. The
cell count using a Neubauer chamber did not reveal any
difference between the two groups. These data confirmed that
the aqueous extract of lavender had no toxic effect on the HepG2
cell line (Figure 6).
3.5 | AChE inhibitory activity
The results of AChE inhibitory activity of aqueous extracts of lavender
at the concentration of 300 μg/ml are illustrated in Figure 7. The plant
extracts showed no enzyme inhibition activity (F3, 11 = 0.368;
p = 0.21).
3.6 | Antioxidant activity
Our findings demonstrated that the lavender’s aerial parts display a
considerable radical scavenging activity dose‐dependently
(F3,8 = 763.712; p < 0.0001). Figure 8 illustrates the severity of
antioxidant activity of different doses of the extract.
However, the extract showed a lower antioxidant activity in
comparison with vitamin C, which was used as standard (Figure 9).
F IGURE 2 The standard chromatogram
sample of caffeic acid (a) and luteolin (b)
[Color figure can be viewed at
wileyonlinelibrary.com]
TABLE 1 The concentration percent of caffeic acid and luteolin in
1ml of aqueous extract of lavender in the wavelengths of 325 and
350 nm, respectively
Wave length (nm) Name of component Concentration (%)
325 Caffeic acid 0.1
























F IGURE 3 Dose‐dependent effect of aqueous extract of lavender
on Aβ polymerization. The doses of 5, 10, and 100 µg/ml significantly
inhibited the polymerization of Aβ (*P < 0.05, compared to CON). Aβ:
amyloid beta
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4 | DISCUSSION
Lavandula angustifolia is an aromatic herbal medicine having multiple
effects. Antioxidative and anti‐inflammatory characteristics are attrib-
uted to lavender (Marín, Sayas‐Barberá, Viuda‐Martos, Navarro, &
Sendra, 2016; Silva et al., 2015) which, in turn, show similarities to the
neuroprotective and neurotrophic properties of the herbal medicine
(Parejo et al., 2002).
The HPLC results verified that the two constituents of the
lavender aqueous extract are the caffeic acid and luteolin. Caffeic
acid is a natural phenolic compound, which has the potential to
minimize oxidative stress and inflammatory responses and may
potentially be of value in the treatment of neurodegenerative
diseases (Bailly & Cotelle, 2005; Pittalà et al., 2015; Yang et al.,
2013). Luteolin, as a flavonoid compound of food, protects
hippocampus against the damage induced by kainic acid in rats (Lin,
Lu, & Wang, 2016). Luteolin also has some other biological functions,
such as relieving neuroinflammation through reduction of proin-
flammatory mediators and antioxidant activity (Jang, Dilger, &
Johnson, 2010; Wang, Wang, Cheng, & Che, 2016). Taken together,
it is suggested that luteolin could potentially be used against
neurodegenerative diseases, including AD. Luteolin is also known to
have memory‐improving effects (Jang, Dilger, & Johnson, 2010).
The accumulation of Aβ is recognized as one of the main cause of
Alzheimer’s disease (Gunther & Strittmatter, 2010). The Aβ plaques
affect the function of N‐methyl‐D‐aspartic acid (NMDA) receptors
(Sinnen, Bowen, Gibson, & Kennedy, 2016). In contrast, the NMDA
ion channel receptors mediate the main excitatory neurotransmis-
sion in the brain and the excessive activity of the receptors is known
to be involved in the Alzheimer’s disease (Dal Prà, Chiarini, & Armato,
2015). It is demonstrated that the administration of lavender extract
can alleviate the extracellular accumulation of the NMDA receptor
and reduce the glutamate neurotoxicity (López, Nielsen, Solas,
Ramírez, & Jäger, 2017). Accordingly, the prevention of Aβ plaque
formation, as reported here, promises probable positive effect of the
F IGURE 4 The AFM imaging of 3D (a) and 2D form (b), and height profile (c) of Aβ peptide treated without the aqueous extract of lavender.
A clear and shining fibril of Aβ is visible. A: angle with horizon (degree); Aβ: amyloid beta; D: distance between the two A points (nm); H: height
(nm) [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 5 The AFM imaging of 3D (a) and 2D form (b), and height profile (c) of Aβ peptide treated with the aqueous extract of lavender. The
extract of lavender inhibited fibril formation of Aβ. A: angle with horizon (degree); AFM: atomic force microscopy; Aβ: amyloid beta; D: distance
between the two A points (nm); H: height (nm) [Color figure can be viewed at wileyonlinelibrary.com]
TABLE 2 The fibril characteristics of Aβ peptide treated with and
without the extract
Aβ H (nm) D (nm) A (degree)
Without the extract 4.090 33.30 18.3
With the extract 0.271 12.47 1.245
Note. A: angle with horizon; Aβ: amyloid beta; D: distance between the
two A points; H: height.
F IGURE 6 The aqueous extract of lavender (100 μg/ml) had no
toxic effect on the HepG2 cell line. The control (a) and treated cell
lines (b) display the same morphology
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aqueous extract of lavender on the neurological disorder, such as the
Alzheimer’s disease (Soheili et al., 2012; Thal, 2015).
The findings of this study indicated that the herbal medicine
displayed no inhibitory effect on the activity of AChE. AChE is found at
the cholinergic synapses, where its activity serves to terminate
synaptic transmission. The cholinergic neurotransmission takes a role
in learning and memory phenomena (Lian et al., 2017). On the basis of
the present results, possible improving role of the lavender on spatial
memory cannot be attributed to its inhibitory effect on the activity of
AChE. A possible mechanism can be cross‐talk between the herbal
extract and the NMDA receptors, known as the important receptors in
neuronal hippocampal circuits involved in the spatial learning and
memory. However, such assumptions need to be further investigated.
A potent antioxidant activity was observed under the in vitro
assessment. Many studies suggested that oxidative stresses promote
the production and deposition of Aβ (Zuo et al., 2015). Oxidative
stress is an imbalance between the production of free radicals in the
body and its ability to quench it through antioxidants (Chang et al.,
2014). There is also evidence that though Aβ deposits lead to more
mitochondrial damage; mitochondria‐targeted antioxidants prevent
abnormal Aβ processing and decrease plaque formation (Han et al.,
2017). Consequently, it can be said that the herbal extract might
have a supporting role in combating the antioxidant activity.
Taken together, the aqueous extract of lavender opposes Aβ
fibrillation and, hence, prevents plaque formation. Further, our
results proved that the herbal medicine displayed antioxidant
activity. Moreover, in the concentrations used in this study, the
lavender extract had no toxic effect. Therefore, due to its biological
properties, the extract could be effective in inhibiting inflammatory
and oxidative effects. Accordingly, some neurological disorders,
including Alzheimer’s disease could possibly be treated by the
lavender aqueous extract.
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